Cargando…

Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases

PURPOSE: Concomitant autoimmune rheumatic diseases (ARD) can add morbidity and complicate treatment decisions for patients with lung cancer. We evaluated the tumour characteristics at diagnosis and clinical outcomes in lung cancer patients with or without ARD. METHODS: This retrospective cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghanem, Paola, Murray, Joseph C, Marrone, Kristen A, Scott, Susan C, Feliciano, Josephine L, Lam, Vincent K, Hann, Christine L, Ettinger, David S, Levy, Benjamin P, Forde, Patrick M, Shah, Ami A, Mecoli, Christopher, Brahmer, Julie, Cappelli, Laura C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619011/ https://www.ncbi.nlm.nih.gov/pubmed/37914179 http://dx.doi.org/10.1136/rmdopen-2023-003471

Ejemplares similares

CLRM-11 ALK TYROSINE KINASE INHIBITOR THERAPY AND BRAIN METASTASES IN NON-SMALL CELL LUNG CANCER: IMPACT ON TUMOR SIZE AND DISTRIBUTION
por: Kamson, David Olayinka, et al.
Publicado: (2023)

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
por: Scott, Susan C., et al.
Publicado: (2022)

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
por: Hsu, Melinda L, et al.
Publicado: (2022)

An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
por: Liang, Kai-li, et al.
Publicado: (2022)

Impact of autoimmune rheumatic diseases on birth outcomes: a population-based study
por: Strouse, Jennifer, et al.
Publicado: (2019)

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
por: Marrone, Kristen A., et al.
Publicado: (2018)

Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control study
por: Gadalla, S M, et al.
Publicado: (2009)

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
por: Balaji, Aanika, et al.
Publicado: (2021)

Review: Cancer‐Induced Autoimmunity in the Rheumatic Diseases
por: Shah, Ami A., et al.
Publicado: (2015)

Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study
por: Marozoff, Shelby, et al.
Publicado: (2022)

Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities
por: Cappelli, Laura C, et al.
Publicado: (2016)

Persistent mutation burden drives sustained anti-tumor immune responses
por: Niknafs, Noushin, et al.
Publicado: (2023)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis
por: Cappelli, Laura C, et al.
Publicado: (2022)

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
por: Furer, Victoria, et al.
Publicado: (2019)

Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
por: Naidoo, Jarushka, et al.
Publicado: (2017)

Risks of myeloid malignancies in patients with autoimmune conditions
por: Anderson, L A, et al.
Publicado: (2009)

Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada
por: McCormick, Natalie, et al.
Publicado: (2017)

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
por: Arumahandi de Silva, Amanthi Nadira, et al.
Publicado: (2022)

Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data
por: Shridharmurthy, Divya, et al.
Publicado: (2022)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Strangfeld, Anja, et al.
Publicado: (2021)

Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
por: Frommert, Leonie Maria, et al.
Publicado: (2022)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

What is the association between adverse childhood experiences and late-life cognitive decline? Study of Healthy Aging in African Americans (STAR) cohort study
por: Lor, Yi, et al.
Publicado: (2023)

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
por: Najm, Aurélie, et al.
Publicado: (2019)

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Publicado: (2021)

COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study
por: Kim, Yun Kyu, et al.
Publicado: (2023)

Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt– a national health survey
por: Branco, Jaime C, et al.
Publicado: (2016)

Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider
por: Ritschl, Valentin, et al.
Publicado: (2020)

Infections in early life and childhood leukaemia risk: a UK case–control study of general practitioner records
por: Cardwell, C R, et al.
Publicado: (2008)

Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
por: Plastiras, Sotiris C, et al.
Publicado: (2021)

Mechanisms of hypertension in autoimmune rheumatic diseases
por: Taylor, Erin B., et al.
Publicado: (2019)

Rheumatic autoimmune diseases in women and midlife health
por: Marder, Wendy, et al.
Publicado: (2015)

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012)

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
por: D’Silva, Kristin M, et al.
Publicado: (2020)

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Wieczorek, Maud, et al.
Publicado: (2022)

Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series
por: ten Hagen, Alexander, et al.
Publicado: (2022)

Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_veovepqb3sldjhhhdorg14naq5